These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8767480)

  • 1. Receptor-ligand interactions in the hepatic uptake of chylomicron remnants studied with genetically manipulated mice.
    Redgrave TG; Mortimer BC; Martins IJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():105-7. PubMed ID: 8767480
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocytic mechanisms for uptake and metabolism of chylomicron remnants in the liver.
    Windler E; Greeve J; Jäckle S; Rinninger F; Pox C; Puchta D; Petkova D; Robenek H; Daerr W; Greten H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():103-4. PubMed ID: 8767479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
    Shimano H; Namba Y; Ohsuga J; Kawamura M; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
    J Clin Invest; 1994 May; 93(5):2215-23. PubMed ID: 8182153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver.
    Windler E; Greeve J; Robenek H; Rinninger F; Greten H; Jäckle S
    Hepatology; 1996 Aug; 24(2):344-51. PubMed ID: 8690403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of chylomicron- and VLDL-remnants leads to atherosclerosis in apoE transgenic mice.
    van Vlijmen BJ; van Ree JH; Frants RR; Hofker MH; Havekes LM
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():113-5. PubMed ID: 8767483
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of chylomicron remnants in transgenic mice expressing apolipoprotein E in the intestine.
    Shimano H; Namba Y; Ohsuga J; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
    Biochem Biophys Res Commun; 1994 Apr; 200(2):716-21. PubMed ID: 8179605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of steps mediating the hepatic uptake and catabolism of chylomicron remnants in rodents--removal from the blood and endocytosis into hepatocytes.
    Havel RJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():99-102. PubMed ID: 8767478
    [No Abstract]   [Full Text] [Related]  

  • 9. The receptor-mediated endocytosis of lipoprotein (a).
    März W; Scharnagl H; Mondorf U; Wieland H; Gross W; Kostner GM
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():131-8. PubMed ID: 8767490
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors.
    Sehayek E; Eisenberg S
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():110-2. PubMed ID: 8767482
    [No Abstract]   [Full Text] [Related]  

  • 11. The uptake of chylomicron remnants by the liver.
    Windler EE
    Adv Exp Med Biol; 1987; 210():131-5. PubMed ID: 3591544
    [No Abstract]   [Full Text] [Related]  

  • 12. State of the art: atherosclerosis in a limited edition.
    Rader DJ; FitzGerald GA
    Nat Med; 1998 Aug; 4(8):899-900. PubMed ID: 9701240
    [No Abstract]   [Full Text] [Related]  

  • 13. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
    Willnow TE; Sheng Z; Ishibashi S; Herz J
    Science; 1994 Jun; 264(5164):1471-4. PubMed ID: 7515194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of apolipoproteins and lipoprotein receptors].
    Itakura H; Matsumoto A
    Nihon Rinsho; 1990 Nov; 48(11):2666-74. PubMed ID: 2125327
    [No Abstract]   [Full Text] [Related]  

  • 18. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicron assembly and catabolism: role of apolipoproteins and receptors.
    Hussain MM; Kancha RK; Zhou Z; Luchoomun J; Zu H; Bakillah A
    Biochim Biophys Acta; 1996 May; 1300(3):151-70. PubMed ID: 8679680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of the interaction between LDL and recombinant apo(a).
    Helmhold M; Ernst A; Brunner C; Breuer U; Armstrong VW; Müller HJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():36-8. PubMed ID: 8767455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.